SCHEMBL6876402

SCHEMBL6876402

CCOC(=O)c1ccc(NC(=O)N[C@H]2CC[C@@H](Nc3nc4c(c(N(C)C)n3)CCCC4)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.49
ABL1 P00519 1/20 0.49
HTT P42858 1/20 0.49
RIN1 Q13671 1/20 0.49
EPHX2 P34913 2/20 0.49
TP53 P04637 4/20 0.44
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
CYP2C19 P33261 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ADRA2A P08913 3/20 0.43
HRH1 P35367 3/20 0.43
HTR2B P41595 3/20 0.43
MCHR1 Q99705 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6876406 1.00 MAPT (0.49) MAPTABL1HTTRIN1EPHX2
SCHEMBL6877142 0.92 RAB9A (0.47) MAPTABL1HTTRIN1EPHX2
SCHEMBL6877139 0.92 RAB9A (0.47) MAPTABL1HTTRIN1EPHX2
SCHEMBL6873795 0.92 MAPT (0.60) MAPTHTTTP53NPC1RAB9A
SCHEMBL6873802 0.92 MAPT (0.60) MAPTHTTTP53NPC1RAB9A
SCHEMBL6868638 0.91 EPHX2 (0.54) EPHX2NPC1RAB9ACYP1A2CYP2C9
SCHEMBL6873572 0.90 GSK3B (0.53) MAPTEPHX2TP53NPC1RAB9A
SCHEMBL6873580 0.90 GSK3B (0.53) MAPTEPHX2TP53NPC1RAB9A
SCHEMBL6879303 0.89 NPC1 (0.55) MAPTEPHX2NPC1RAB9AALDH1A1
SCHEMBL6879296 0.89 NPC1 (0.55) MAPTEPHX2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed